DR REDDYS LABORATORIES
Back to Income Statement
|
DR REDDYS LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹32,644 Cr | ₹28,011 Cr | ₹24,670 Cr | ₹21,545 Cr | ₹19,048 Cr |
What is the latest Revenue of DR REDDYS LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹32,644 Cr |
| Mar2025 | ₹28,011 Cr |
| Mar2024 | ₹24,670 Cr |
| Mar2023 | ₹21,545 Cr |
| Mar2022 | ₹19,048 Cr |
How is Revenue of DR REDDYS LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹32,644 Cr | 16.54 | |
| Mar2025 | ₹28,011 Cr | 13.54 | |
| Mar2024 | ₹24,670 Cr | 14.50 | |
| Mar2023 | ₹21,545 Cr | 13.11 | |
| Mar2022 | ₹19,048 Cr | - | |
Compare Revenue of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹115,856.1 Cr | -0.4% | 13.1% | 13.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,688.0 Cr | -2% | 6% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹295,080.0 Cr | -4% | 22.9% | 75.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,677.0 Cr | -1.8% | 1.8% | 21.9% | Stock Analytics | |
| CIPLA | ₹111,731.0 Cr | -0.9% | 4.5% | -8% | Stock Analytics | |
| MANKIND PHARMA | ₹107,613.0 Cr | -1.4% | 11.5% | 19.5% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -0.4% |
13.1% |
13.7% |
| SENSEX | 1.8% |
11.1% |
-1.6% |
You may also like the below Video Courses